A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone
Clinical trial NCT06689163 · RECRUITING
Trial details
- NCT number
- NCT06689163
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-11
- Primary completion
- 2025-11-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.